See what people are saying about BD Nano with PentaPointâ„¢ Comfort!




     

See What Key Opinion Leaders are saying  

  

 

 

 

 

 

 

See What Patients are Saying 

 

See What Patients are Saying

BD Nano and Patient Comfort
 

Pain from injection devices is affected by needle length, diameter, needle polishing, lubrication, and needle tip geometry. Did you know 47% of people with diabetes would be more likely to administer their injections regularly if a product was available that would ease the pain and discomfort of injections.1 72% of patients who tried the new BD Nano preferred it over their current pen needle.2

Laboratory testing demonstrated a significant 23% reduction in average penetration force for the new 5-bevel vs current 3-bevel pen needles. When asked to test a new pen needle at home, patients rated the 5-bevel needle significantly more comfortable, easier to insert, preferable, and less painful.4

% of subjects who selected the 3- or 5-bevel needles after home use for ease of insertion, comfort and preference#

BD Nano just got better with PentaPointTM
 

BD Nano has been shown to be less intimidating. 3

  • 88% of the patients reported feeling “not at all anxious” after seeing the 4mm pen needle

BD Nano is proven less painful. 3

  • In a clinical trial, 64% of patients found the BD Nano to be more comfortable than both the 5mm and 8mm pen needles

BD Nano enables greater site flexibility and site rotation for ALL patients. 4

  • BD Nano is easier to teach, learn and use.
     
  • Allows for a single-handed, no-pinch technique, which:
    • is easier and more convenient because it eliminates a step in the injection process
       
    • makes it easier for patients to inject in areas that are hard to reach when using two hands, such as the back of the arm and the buttock
       
  • So short that patients can confidently inject in areas that have less fat, such as the outer thigh.

See for yourself! >

1. AADE Injection Impact Survey, 2007.

2,3: Data on file

4. Hirsch LJ, Gibney MA, Albanese J, et al. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin. 2010; 26 (6): 1531–1541.

 



Important Note: The content of this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Do not disregard your doctor's advice or delay in seeking it because of something you have read in this website.

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2014 BD